Thursday, January 30, 2020

Synedgen Raises $2.6M

Claremont-based Synedgen, a biotechnology company developing wound care technology, said this morning that it has raised $2.6M in funding. Source of the funding was not announced. According to the company, the funding will go towards commercialization of two, U. S. Food and Drug Administration (FDA) 510(k)-cleared products for wound care. The comopany

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.